Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

425 ARTÍCULOS , VIENDO DEL 376 AL 390

Reconsideration of Anticholinesterase Therapeutic Strategies against Alzheimer's Disease

Wang H, Zhang H.

ACS Chem Neurosci. 2019 Feb 20;10(2):852-862. doi: 10.1021/acschemneuro.8b00391. Epub 2018 Dec 6.

Translating the biology of aging into novel therapeutics for Alzheimer disease

Hara Y, McKeehan N, Fillit HM.

Neurology. 2019 Jan 8;92(2):84-93. doi: 10.1212/WNL.0000000000006745. Epub 2018 Dec 7.

Structure-Based Survey of the Binding Modes of BACE1 Inhibitors

Hu H, Chen Z, Xu X, Xu Y.

ACS Chem Neurosci. 2019 Feb 20;10(2):880-889. doi: 10.1021/acschemneuro.8b00420. Epub 2018 Dec 27.

Alzheimer's disease: understanding homeostasis deregulation to foster development of effective therapies

Nisticò R, Peineau S.

Pharmacol Res. 2019 Jan;139:467-468. doi: 10.1016/j.phrs.2018.12.011. Epub 2018 Dec 13.

The ketogenic diet as a potential treatment and prevention strategy for Alzheimer's disease

Broom GM, Shaw IC, Rucklidge JJ.

Nutrition. 2019 Apr;60:118-121. doi: 10.1016/j.nut.2018.10.003. Epub 2018 Oct 10.

Efficacy and safety of idalopirdine for Alzheimer's disease: a systematic review and meta-analysis

Matsunaga S, Fujishiro H, Takechi H.

Int Psychogeriatr. 2019 Nov;31(11):1627-1633. doi: 10.1017/S1041610218002156. Epub 2018 Dec 18.

Alzheimer's disease therapeutic candidate SAK3 is an enhancer of T-type calcium channels

Fukunaga K, Izumi H, Yabuki Y, Shinoda Y, Shioda N, Han F.

J Pharmacol Sci. 2019 Feb;139(2):51-58. doi: 10.1016/j.jphs.2018.11.014. Epub 2018 Dec 18.

Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer's disease: A randomized, double-blind, controlled trial

Tamtaji OR, Heidari-Soureshjani R, Mirhosseini N, Kouchaki E, Bahmani F, Aghadavod E, Tajabadi-Ebrahimi M, Asemi Z.

Clin Nutr. 2019 Dec;38(6):2569-2575. doi: 10.1016/j.clnu.2018.11.034. Epub 2018 Dec 10.

Adiponectin and sporadic Alzheimer's disease: Clinical and molecular links

Letra L, Rodrigues T, Matafome P, Santana I, Seiça R.

Front Neuroendocrinol. 2019 Jan;52:1-11. doi: 10.1016/j.yfrne.2017.10.002. Epub 2017 Oct 13.

Prevalence of delusions in drug-naïve Alzheimer disease patients: A meta-analysis

Lai L, Lee PE, Chan P, Fok MC, Hsiung GR, Sepehry AA.

Int J Geriatr Psychiatry. 2019 Sep;34(9):1287-1293. doi: 10.1002/gps.4812. Epub 2017 Oct 11.

Older Adults with Alzheimer's Disease Who Have Used an Automatic Medication Dispenser for 3 or More Years

Kamimura T.

Clin Gerontol. 2019 Jan-Feb;42(1):127-133. doi: 10.1080/07317115.2017.1347594. Epub 2017 Oct 13.

Therapeutic efficacy of the Ginkgo special extract EGb761(®) within the framework of the mitochondrial cascade hypothesis of Alzheimer's disease

Müller WE, Eckert A, Eckert GP, Fink H, Friedland K, Gauthier S, Hoerr R, Ihl R, Kasper S, Möller HJ.

World J Biol Psychiatry. 2019 Mar;20(3):173-189. doi: 10.1080/15622975.2017.1308552. Epub 2017 May 2.

A circuit view of deep brain stimulation in Alzheimer's disease and the possible mechanisms

Yu D, Yan H, Zhou J, Yang X, Lu Y, Han Y.

Mol Neurodegener. 2019 Aug 8;14(1):33. doi: 10.1186/s13024-019-0334-4.

Antioxidant Properties of Crocus Sativus L. and Its Constituents and Relevance to Neurodegenerative Diseases; Focus on Alzheimer's and Parkinson's Disease

Hatziagapiou K, Kakouri E, Lambrou GI, Bethanis K, Tarantilis PA.

Curr Neuropharmacol. 2019;17(4):377-402. doi: 10.2174/1570159X16666180321095705.

Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer's and Parkinson's Diseases

Batista AF, Bodart-Santos V, De Felice FG, Ferreira ST.

CNS Drugs. 2019 Mar;33(3):209-223. doi: 10.1007/s40263-018-0593-6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias